Evidence map›Paper›PMID 35816502›Full record

ArticleMagnetic resonance in medicine2022

Deuterium MRSI of tumor cell death in vivo following oral delivery of

Friederike Hesse, Alan J Wright, Flaviu Bulat, Vencel Somai, Felix Kreis, Kevin M Brindle

Open access · hybridAbstract read
In one paragraph

Article in Magnetic resonance in medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed, 1 pooled it
2.6field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 1 synthesis or guideline pooled it, 19 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Early Detection of Cell Death Using Transmembrane Water Exchange Magnetic Resonance Imaging.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. New Horizons in HyperpolarizedMolecular imaging and biology · 2024
    Article
  9. Observational
  10. Review
  11. Assessment of the sensitivity ofNMR in biomedicine · 2023
    Article
  12. Review
  13. Article
  14. Monitoring Response to Treatment with Oral [2,3-Radiology. Imaging cancer · 2022
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Friederike HesseCancer Research UK Cambridge Institute, Cambridge, UK.ORCID 0000-0001-5427-7564
Alan J WrightCancer Research UK Cambridge Institute, Cambridge, UK.ORCID 0000-0002-4577-5681
Flaviu BulatCancer Research UK Cambridge Institute, Cambridge, UK.
Vencel SomaiCancer Research UK Cambridge Institute, Cambridge, UK.ORCID 0000-0001-9874-526X
Felix KreisCancer Research UK Cambridge Institute, Cambridge, UK.ORCID 0000-0003-3340-3861
Kevin M BrindleCancer Research UK Cambridge Institute, Cambridge, UK.ORCID 0000-0003-3883-6287
Cancer Research UK Cambridge Center · GBUniversity of Cambridge · GB

Funding

Cancer Research UK 17242Cancer Research UK 28289Cancer Research UK C197/A16465Cancer Research UK C197/A17242Cancer Research UK C9685/A25177
6 · The paper itself

Abstract

purposeThere is an unmet clinical need for direct and sensitive methods to detect cell death in vivo, especially with regard to monitoring tumor treatment response. We have shown previously that tumor cell death can be detected in vivo from

methodsMice with subcutaneously implanted EL4 tumors were fasted for 1 h before administration (200 μl) of [2,3-

resultsThe malate/fumarate signal ratio increased from 0.022 ± 0.03 before drug treatment to 0.12 ± 0.04 following treatment (p = 0.023, n = 4). Labeled malate was undetectable in spectroscopic images acquired before treatment and increased in the tumor area following treatment. The increase in the malate/fumarate signal ratio was similar to that observed previously following intravenous administration of labeled fumarate.

conclusionOrally administered [2,3-

Indexed as

FumaratesNeoplasmsAnimalsCell DeathDeuteriumMalatesMiceDeuteriumFumaratesMalates

Identifiers

PMID35816502
PMCPMC9545469
OpenAlexW4285037252

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.